CATALOGO DEI PRODOTTI DELLA RICERCA

LAWLOR, Rita Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.236
NA - Nord America 10.073
AS - Asia 8.058
SA - Sud America 1.326
AF - Africa 342
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 5
Totale 30.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.755
RU - Federazione Russa 4.069
SG - Singapore 3.002
CN - Cina 2.090
IT - Italia 1.821
GB - Regno Unito 1.480
BR - Brasile 1.058
HK - Hong Kong 803
VN - Vietnam 740
DE - Germania 600
IE - Irlanda 474
SE - Svezia 421
FR - Francia 411
BD - Bangladesh 390
KR - Corea 247
FI - Finlandia 243
NL - Olanda 171
CA - Canada 166
IN - India 162
JP - Giappone 96
UA - Ucraina 91
ES - Italia 89
MX - Messico 89
AR - Argentina 84
AT - Austria 81
TR - Turchia 74
ID - Indonesia 71
ZA - Sudafrica 60
PL - Polonia 59
NG - Nigeria 58
AU - Australia 53
IQ - Iraq 52
JO - Giordania 52
TG - Togo 50
EC - Ecuador 46
PK - Pakistan 43
BE - Belgio 42
VE - Venezuela 37
CO - Colombia 33
BJ - Benin 32
SA - Arabia Saudita 31
MA - Marocco 30
UZ - Uzbekistan 30
KE - Kenya 27
CL - Cile 25
IR - Iran 23
LT - Lituania 22
CH - Svizzera 21
PY - Paraguay 20
CZ - Repubblica Ceca 19
PH - Filippine 17
MY - Malesia 16
BF - Burkina Faso 15
EG - Egitto 15
TN - Tunisia 15
ET - Etiopia 13
AZ - Azerbaigian 11
IL - Israele 11
KG - Kirghizistan 11
BG - Bulgaria 10
LV - Lettonia 10
NP - Nepal 10
PT - Portogallo 10
RO - Romania 10
AE - Emirati Arabi Uniti 9
GR - Grecia 9
HR - Croazia 9
OM - Oman 9
RS - Serbia 9
CR - Costa Rica 8
DZ - Algeria 8
SK - Slovacchia (Repubblica Slovacca) 8
AM - Armenia 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
PA - Panama 7
PE - Perù 7
TH - Thailandia 7
TW - Taiwan 7
UY - Uruguay 7
AL - Albania 6
HN - Honduras 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
SI - Slovenia 6
SV - El Salvador 6
LB - Libano 5
MD - Moldavia 5
NI - Nicaragua 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
CY - Cipro 4
HU - Ungheria 4
LU - Lussemburgo 4
NO - Norvegia 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
UG - Uganda 4
AD - Andorra 3
Totale 30.040
Salva come PNG Salva come JPEG
Città #
Singapore 1.606
Moscow 1.403
Ashburn 1.317
Southend 1.154
San Jose 1.078
Dallas 1.029
Chandler 945
Verona 828
Hong Kong 786
Beijing 444
Dublin 434
The Dalles 423
New York 335
Council Bluffs 321
Jacksonville 251
Ann Arbor 213
Los Angeles 209
Ho Chi Minh City 197
Woodbridge 182
Munich 175
Hanoi 144
Lawrence 134
Princeton 134
Wilmington 130
Jinan 123
Houston 117
Santa Clara 114
Buffalo 111
São Paulo 107
Redondo Beach 99
Nanjing 93
Helsinki 89
Shenyang 88
Redmond 87
Dong Ket 82
Columbus 81
Milan 79
London 77
Tokyo 72
Nuremberg 66
Sindelfingen 66
Hebei 65
Orem 60
Zhengzhou 59
Seattle 57
Abuja 52
Montreal 52
Tianjin 52
Lomé 50
Turku 50
Amman 49
Vienna 47
Frankfurt am Main 46
Warsaw 46
Amsterdam 44
Guangzhou 44
Rome 44
Brussels 42
Jakarta 41
Lappeenranta 41
Haikou 40
Madrid 40
Stockholm 40
Toronto 40
Changsha 39
Hangzhou 39
Johannesburg 39
Ningbo 38
Brooklyn 37
Nanchang 36
Poplar 36
Denver 35
Haiphong 35
Phoenix 35
Washington 35
Taizhou 34
Rio de Janeiro 33
Chennai 32
Cotonou 32
Jiaxing 32
Chicago 31
Mexico City 31
Seoul 31
Brescia 30
Falkenstein 30
Redwood City 30
Taiyuan 30
Da Nang 29
Bologna 28
Manchester 28
Dearborn 27
Atlanta 26
Shanghai 26
Tashkent 26
Ankara 25
Belo Horizonte 25
San Francisco 25
Boardman 24
Curitiba 24
Sydney 24
Totale 17.641
Salva come PNG Salva come JPEG
Nome #
Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research 578
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 303
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 283
Whole-genome landscape of pancreatic neuroendocrine tumours 281
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 267
Genomic characterization of hepatoid tumors: context matters 261
1177PUndiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC) 254
Genomic analyses identify molecular subtypes of pancreatic cancer 254
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 252
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 248
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 239
Gα15 in early onset of pancreatic ductal adenocarcinoma 239
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 230
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 228
A multimodality test to guide the management of patients with a pancreatic cyst 220
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 219
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 217
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 216
RON is not a prognostic marker for resectable pancreatic cancer 211
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 209
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 206
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 203
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 203
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 202
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 201
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 201
428OImmune landscape of pancreatic neuroendocrine tumours (PanNETs) 201
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 199
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 198
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 197
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 196
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 196
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk 195
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 195
Sex differences in oncogenic mutational processes 195
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 194
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 194
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 192
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 192
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 192
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 191
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 190
Reporting tumor molecular heterogeneity in histopathological diagnosis 190
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 189
Lost in translation: returning germline genetic results in genome-scale cancer research 188
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 188
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 188
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 188
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 185
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 185
Comparative Lesions Analysis Through a Targeted Sequencing Approach 185
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer 185
Author Correction: The landscape of viral associations in human cancers 183
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 182
Divergent mutational processes distinguish hypoxic and normoxic tumours 180
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 179
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 177
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 177
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 175
Hypermutation In Pancreatic Cancer 174
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 174
Research capacity. Enabling the genomic revolution in Africa 173
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 173
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 172
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 171
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
Splice variants as novel targets in pancreatic ductal adenocarcinoma 170
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 170
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan 170
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 167
Loss of FGFR4 promotes the malignant phenotype of PDAC 166
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 166
Genome-wide association study identifies an early onset pancreatic cancer risk locus 165
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 165
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 164
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 163
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 162
Exosomal miRNA signatures of pancreatic lesions 161
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 161
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 160
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 158
International network of cancer genome projects 157
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 156
A Model of Collaboration ad Experiences between Bio-industry and Academic Biobanks 156
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 156
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 155
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer 154
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 154
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 154
Pan-cancer analysis of whole genomes 154
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 154
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 153
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 153
Biosampling and biobanking (Chapter7) 150
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 149
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 149
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 149
Long-term organoid culture of a small intestinal neuroendocrine tumor 147
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 147
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 147
Totale 19.236
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.279
article - articoli 97.008
book - libri 1.203
conference - conferenze 1.330
curatela - curatele 0
other - altro 1.179
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.559
Totale 204.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 0 0 0 0 0 0 0 0 152
2021/20221.318 127 354 75 114 52 33 54 90 51 32 81 255
2022/20232.624 160 320 203 439 219 619 45 165 291 35 89 39
2023/20241.877 57 124 125 168 177 330 95 192 56 129 305 119
2024/20255.563 298 285 329 815 309 299 429 340 704 346 522 887
2025/202615.295 1.058 735 1.147 2.330 3.522 957 1.336 873 1.319 908 534 576
Totale 30.612